R. C.
Chairman of the Board, Chief Executive Officer and
Biotechnology
Nouscom
Italy
Biography
Riccardo founded the genetic vaccine company Okairos in 2007 and led the company through its successful acquisition by GSK in 2013. He continues to lead the related service and GMP manufacturing company in the field of infectious diseases, Keires AG in Basel.Previously, Riccardo was the founder and head of the Istituto di Ricerche di Biologia Molecolare (IRBM) in Rome, Italy, which later became a subsidiary of Merck Inc. Before that, he established the Gene Expression Unit at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany.
Research Interest
immunology, molecular medicine and drug discover
